Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Takeda To Buy Brazil’s Multilab

by Ann M. Thayer
June 4, 2012 | A version of this story appeared in Volume 90, Issue 23

Takeda Pharmaceutical has agreed to acquire Brazil’s Multilab Indústria e Comércio de Produtos Farmacêuticos for $249 million up front and up to $20 million in milestone payments. In 2011, Multilab had sales of $70 million, primarily of branded generic and over-the-counter drugs. Takeda already manufactures prescription and OTC products in the country. According to the Japanese company, buying 24-year-old Multilab will make it one of the top 10 pharmaceutical companies in Brazil.

Article:

This article has been sent to the following recipient:

1 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.